Triple

T16861146
Position Surface form Disambiguated ID Type / Status
Subject Office of Tissues and Advanced Therapies E409911 entity
Predicate website P69 FINISHED
Object https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/office-tissues-and-advanced-therapies E409911 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/office-tissues-and-advanced-therapies | Statement: [Office of Tissues and Advanced Therapies, website, https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/office-tissues-and-advanced-therapies]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/office-tissues-and-advanced-therapies
Context triple: [Office of Tissues and Advanced Therapies, website, https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/office-tissues-and-advanced-therapies]
  • A. Office of Tissues and Advanced Therapies chosen
    The Office of Tissues and Advanced Therapies is a U.S. FDA office responsible for regulating cellular and gene therapies, tissue-based products, and other advanced biologic treatments.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. FDA CFSAN
    FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
  • D. Center for Devices and Radiological Health
    The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
  • E. U.S. Food and Drug Administration Office of Regulatory Science
    The U.S. Food and Drug Administration Office of Regulatory Science is an FDA division that conducts scientific research and analysis to support regulatory decisions on the safety, effectiveness, and quality of food, drugs, and other products under the agency’s oversight.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d88395e6c88190b22730f335107c14 completed April 10, 2026, 4:59 a.m.
NER Named-entity recognition batch_69e3b5036e6c8190a3b9e525a34da2e1 completed April 18, 2026, 4:44 p.m.
NED1 Entity disambiguation (via context triple) batch_6a00bb274ba48190951acde0821e05a0 completed May 10, 2026, 5:06 p.m.
Created at: April 10, 2026, 5:24 a.m.